Eva Sum

Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy

Maud Mayoux, Andreas Roller, Vesna Pulko et al. · Science Translational Medicine · 2020 · 380 citations

Life Sciences, Immunology, Oncology +17

Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity

Eva Sum, Moritz Rapp, Philipp Fröbel et al. · Clinical Cancer Research · 2021 · 66 citations · Full text

Medicine, Immunology, Oncology +17

CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors

Sara Labiano, Vincent Roh, Céline Godfroid et al. · Clinical Cancer Research · 2021 · 41 citations · Full text

Medicine, Oncology, Radiation Oncology +14

The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation

Eva Sum, Moritz Rapp, Harald Dürr et al. · Journal for ImmunoTherapy of Cancer · 2022 · 24 citations · Full text

Life Sciences, Immunology, Oncology +17

Tonic and Phasic Pyloric Activity in Response to CCK-Octapeptide

Frank K. Friedenberg, Joshua DeSipio, Annapurna Korimilli et al. · Digestive Diseases and Sciences · 2008 · 17 citations

Medicine, Neuroscience, Pharmacology +7